Literature DB >> 10868902

Colorectal cancer prevention and treatment.

C R Boland1, F A Sinicrope, D E Brenner, J M Carethers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868902     DOI: 10.1016/s0016-5085(00)70010-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  33 in total

1.  Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.

Authors:  Robert P Sellers; Leslie D Alexander; Victoria A Johnson; Chun-Chieh Lin; Jeremiah Savage; Ricardo Corral; Jason Moss; Tim S Slugocki; Erinprit K Singh; Melinda R Davis; Suchitra Ravula; Jamie E Spicer; Jenna L Oelrich; Andrea Thornquist; Chung-Mao Pan; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2010-07-22       Impact factor: 3.641

2.  Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.

Authors:  John M Carethers
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

3.  Clement Richard Boland, Jr., MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Clement Richard Boland
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

4.  Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.

Authors:  J M Carethers
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

5.  Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.

Authors:  C Lamberti; S Lundin; M Bogdanow; C Pagenstecher; N Friedrichs; R Büttner; T Sauerbruch
Journal:  Int J Colorectal Dis       Date:  2006-05-25       Impact factor: 2.571

6.  DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells.

Authors:  Moriya Iwaizumi; Stephanie Tseng-Rogenski; John M Carethers
Journal:  Cancer Biol Ther       Date:  2011-10-15       Impact factor: 4.742

7.  Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study.

Authors:  Carmela Di Gregorio; Piero Benatti; Lorena Losi; Luca Roncucci; Giuseppina Rossi; Giovanni Ponti; Massimiliano Marino; Monica Pedroni; Alessandra Scarselli; Barbara Roncari; Maurizio Ponz de Leon
Journal:  Int J Colorectal Dis       Date:  2004-12-09       Impact factor: 2.571

8.  Ex vivo sentinel lymph node study for rectal adenocarcinoma: preliminary study.

Authors:  Olivier Baton; Philippe Lasser; Jean-Christophe Sabourin; Valérie Boige; Pierre Duvillard; Dominique Elias; David Malka; Michel Ducreux; Marc Pocard
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 9.  Chemotherapeutic implications in microsatellite unstable colorectal cancer.

Authors:  Won-Seok Jo; John M Carethers
Journal:  Cancer Biomark       Date:  2006       Impact factor: 4.388

10.  Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer?

Authors:  John M Carethers
Journal:  Curr Colorectal Cancer Rep       Date:  2010-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.